These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33882617)

  • 1. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo.
    Cheng Q; Bao L; Li M; Chang K; Yi X
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo.
    Zhou B; Xia M; Wang B; Thapa N; Gan L; Sun C; Guo E; Huang J; Lu Y; Cai H
    J Ovarian Res; 2019 Nov; 12(1):107. PubMed ID: 31703731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe
    Ni M; Zhou J; Zhu Z; Xu Q; Yin Z; Wang Y; Zheng Z; Zhao H
    Phytomedicine; 2023 Apr; 112():154701. PubMed ID: 36773431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
    Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
    Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.
    Li Y; Yan H; Xu X; Liu H; Wu C; Zhao L
    Oncol Lett; 2020 Jan; 19(1):323-333. PubMed ID: 31897145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS.
    Wang L; Wang C; Li X; Tao Z; Zhu W; Su Y; Choi WS
    Cell Mol Biol Lett; 2023 May; 28(1):36. PubMed ID: 37131152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells.
    Battaglia AM; Sacco A; Perrotta ID; Faniello MC; Scalise M; Torella D; Levi S; Costanzo F; Biamonte F
    Front Oncol; 2022; 12():868351. PubMed ID: 35433479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer.
    Gai C; Yu M; Li Z; Wang Y; Ding D; Zheng J; Lv S; Zhang W; Li W
    J Cell Physiol; 2020 Apr; 235(4):3329-3339. PubMed ID: 31541463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis.
    Li Y; Zeng X; Lu D; Yin M; Shan M; Gao Y
    Hum Reprod; 2021 Mar; 36(4):951-964. PubMed ID: 33378529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells.
    Hao S; Yu J; He W; Huang Q; Zhao Y; Liang B; Zhang S; Wen Z; Dong S; Rao J; Liao W; Shi M
    Neoplasia; 2017 Dec; 19(12):1022-1032. PubMed ID: 29144989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance.
    Liu N; Lin X; Huang C
    Br J Cancer; 2020 Jan; 122(2):279-292. PubMed ID: 31819185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.
    Shibata Y; Yasui H; Higashikawa K; Miyamoto N; Kuge Y
    PLoS One; 2019; 14(12):e0225931. PubMed ID: 31800616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells.
    Gai C; Liu C; Wu X; Yu M; Zheng J; Zhang W; Lv S; Li W
    Cell Death Dis; 2020 Sep; 11(9):751. PubMed ID: 32929075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPEB1 enhances erastin-induced ferroptosis in gastric cancer cells by suppressing twist1 expression.
    Wang J; Wang T; Zhang Y; Liu J; Song J; Han Y; Wang L; Yang S; Zhu L; Geng R; Li W; Yu X
    IUBMB Life; 2021 Sep; 73(9):1180-1190. PubMed ID: 34184391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.
    Wu X; Liu C; Li Z; Gai C; Ding D; Chen W; Hao F; Li W
    Mol Cell Biochem; 2020 Oct; 473(1-2):217-228. PubMed ID: 32642794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
    Liu Q; Wang K
    Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis.
    Liu M; Fan Y; Li D; Han B; Meng Y; Chen F; Liu T; Song Z; Han Y; Huang L; Chang Y; Cao P; Nakai A; Tan K
    Mol Oncol; 2021 Aug; 15(8):2084-2105. PubMed ID: 33675143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.
    Geng N; Shi BJ; Li SL; Zhong ZY; Li YC; Xua WL; Zhou H; Cai JH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3826-3836. PubMed ID: 29949159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells.
    Bai T; Liang R; Zhu R; Wang W; Zhou L; Sun Y
    J Cell Physiol; 2020 Jul; 235(7-8):5637-5648. PubMed ID: 31960438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.